Exprimo
Mechelen
About Exprimo
Exprimo focuses on the application of population PK, advanced PK/PD and drug-disease modelling & simulation to help decision making in drug development. Our experienced team can help you to make fast and well-informed decisions at all stage of drug development. Our approaches facilitate maximal use of in-house knowledge, fewer study failures and knowledge-based communication within the project team, the organization and with regulators. With many years of experience and over 300 modeling and simulation projects performed, we have built a strong platform for long term relationships with our clients, 75% is repeat business. Thanks to the collaboration with SGS, our flexible and personal approach is complemented by a strong quality contract service organization.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Website: exprimo.com
- Phone: +32 2 657 11 50
Social Profiles
Canonical: https://fsome.com/organization/exprimo-2009970 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.